Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta-analysis.

Clin Cardiol · 2020 · PMC7244304 · PMID 31944351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Our analysis demonstrated the risk of periprocedural thromboembolic events was 0.89% and 0.46% for the bridged and non‐bridged patients, respectively, and the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.